Hengrui Medicine (600276.SH) completed the repurchase of 12.9051 million shares, costing 601 million yuan.

Zh tng cijng APP xn, hng ru y yo (600276.SH) gnggo, 2025 nin 5 yu 14 r, gngs bnc hugu gfn qxin ji mn, bnc hu gu gfn shxing wnchng, shj hugu gngs gfn 1290.51 wn g, zhn gngs zng gbn de bl wi 0.20%, zugo chngji ji wi 57.01 yun/g, zud chngji ji wi 39.00 yun/g, hu gu jnji yu wi 46.59 yun/g, chngji zng jing 6.01 y yun (b hn jioy fiyng). Zhtong Finance APP News, Hengrui Medicine (600276.SH) announced that on May 14, 2025, the company's current share repurchase period has expired, and the share repurchase has been completed. The actual repurchased shares of the company are 12.9051 million shares, accounting for 0.20% of the total share capital of the company. The highest transaction price was 57.01 yuan/share, the lowest transaction price was 39.00 yuan/share, and the average repurchase price was approximately 46.59 yuan/share. The total transaction amount was 6.01 billion yuan (excluding transaction costs).